Parnell Living Science
Overland Park
About Parnell Living Science
Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter. With a world-class, FDA-accredited manufacturing facility in Sydney and operations in the United States, Canada, Middle East and Asia-Pacific, Parnell is committed to continued development of innovative products at the highest standard. Parnell currently markets products for companion, performance and production animals enhanced with proprietary software platforms designed to improve compliance and clinical outcomes. Parnell is poised to bring several new products to market over the next five years addressing up to twelve indications and needs, with a particular focus on the companion animal sector. At Parnell, we believe the combination of our current product portfolio, pipeline of product candidates and business solutions position us to become a leading innovator in animal health. Our value-added approach establishes us as a business partner with our customers, not a commodity provider. That is the Parnell difference.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $52.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Feb 2021)
- Ticker: otcpink:PARNF
- Website: parnell.com
- Phone: 800-887-2763
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/parnell-living-science-119049 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.